The Microbiome in PDAC-Vantage Point for Future Therapies?

Nina Pfisterer1,2, Catharina Lingens1, Cathleen Heuer1

  • 1Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Center Goettingen, 37075 Goettingen, Germany.

Cancers
|December 11, 2022
PubMed
Summary

The tumor microbiome influences pancreatic cancer (pancreatic ductal adenocarcinoma, PDAC) development and outcomes. Understanding intratumoral microbes is key for new diagnostic and therapeutic strategies, but contamination challenges must be addressed.